- The $9 billion tech giant promises faster, easier and more accessible blood tests
- The FDA has signed off on only one of the hundreds of tests they currently offer
- Theranos doesn't publish its results in peer reviewed scientific journals; the company says it will release data in the future
(CNN)Theranos, a medical testing company that uses proprietary technology to take and test patients' blood and other bodily fluids, is also a Silicon Valley sweetheart led by a young, charismatic founder who is also one of America's youngest female billionaires. Elizabeth Holmes, 31, promises her company is "pioneering a new paradigm in which lab testing is accessible and affordable for everyone." Exactly how Theranos does that is still a bit of a mystery. The company is estimated to be worth $9 billion.